ABT logo

Abbott Laboratories (ABT) EBIT

Annual EBIT:

$6.85B+$416.00M(+6.46%)
December 31, 2024

Summary

  • As of today, ABT annual earnings before interest & taxes is $6.85 billion, with the most recent change of +$416.00 million (+6.46%) on December 31, 2024.
  • During the last 3 years, ABT annual EBIT has fallen by -$2.35 billion (-25.53%).
  • ABT annual EBIT is now -25.53% below its all-time high of $9.20 billion, reached on December 31, 2021.

Performance

ABT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

Quarterly EBIT:

$2.03B-$44.00M(-2.12%)
September 30, 2025

Summary

  • As of today, ABT quarterly earnings before interest & taxes is $2.03 billion, with the most recent change of -$44.00 million (-2.12%) on September 30, 2025.
  • Over the past year, ABT quarterly EBIT has increased by +$212.00 million (+11.66%).
  • ABT quarterly EBIT is now -29.64% below its all-time high of $2.88 billion, reached on March 31, 2022.

Performance

ABT Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM EBIT:

$7.78B+$212.00M(+2.80%)
September 30, 2025

Summary

  • As of today, ABT TTM earnings before interest & taxes is $7.78 billion, with the most recent change of +$212.00 million (+2.80%) on September 30, 2025.
  • Over the past year, ABT TTM EBIT has increased by +$1.03 billion (+15.24%).
  • ABT TTM EBIT is now -24.35% below its all-time high of $10.29 billion, reached on June 30, 2022.

Performance

ABT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ABT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+6.5%+11.7%+15.2%
3Y3 Years-25.5%+19.2%-16.9%
5Y5 Years+49.2%+39.4%+81.7%

ABT EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-25.5%+6.5%-2.1%+46.6%-16.9%+29.1%
5Y5-Year-25.5%+49.2%-29.6%+46.6%-24.4%+81.7%
All-TimeAll-Time-25.5%+1920.9%-29.6%+175.1%-24.4%+557.8%

ABT EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$2.03B(-2.1%)
$7.78B(+2.8%)
Jun 2025
-
$2.07B(+22.9%)
$7.57B(+5.4%)
Mar 2025
-
$1.69B(-15.2%)
$7.18B(+4.4%)
Dec 2024
$6.85B(+6.5%)
$1.99B(+9.5%)
$6.88B(+1.9%)
Sep 2024
-
$1.82B(+7.8%)
$6.75B(+2.1%)
Jun 2024
-
$1.69B(+21.7%)
$6.61B(+2.7%)
Mar 2024
-
$1.39B(-25.7%)
$6.44B(-0.2%)
Dec 2023
$6.43B(-23.0%)
$1.86B(+11.1%)
$6.45B(+7.0%)
Sep 2023
-
$1.68B(+11.1%)
$6.03B(-0.4%)
Jun 2023
-
$1.51B(+7.9%)
$6.05B(-12.0%)
Mar 2023
-
$1.40B(-2.8%)
$6.88B(-17.8%)
Dec 2022
$8.36B(-9.1%)
$1.44B(-15.4%)
$8.36B(-10.7%)
Sep 2022
-
$1.70B(-27.0%)
$9.37B(-8.9%)
Jun 2022
-
$2.33B(-19.1%)
$10.29B(+3.4%)
Mar 2022
-
$2.88B(+17.9%)
$9.95B(+8.2%)
Dec 2021
$9.20B(+73.9%)
$2.45B(-6.7%)
$9.20B(+0.4%)
Sep 2021
-
$2.62B(+31.2%)
$9.17B(+14.6%)
Jun 2021
-
$2.00B(-6.3%)
$8.00B(+20.4%)
Mar 2021
-
$2.13B(-11.6%)
$6.64B(+25.6%)
Dec 2020
$5.29B(+15.2%)
$2.41B(+65.8%)
$5.29B(+23.6%)
Sep 2020
-
$1.46B(+126.8%)
$4.28B(+6.3%)
Jun 2020
-
$642.00M(-17.6%)
$4.03B(-12.0%)
Mar 2020
-
$779.00M(-44.6%)
$4.58B(+0.4%)
Dec 2019
$4.59B(+19.4%)
$1.41B(+16.9%)
$4.56B(+5.3%)
Sep 2019
-
$1.20B(+1.0%)
$4.33B(+3.6%)
Jun 2019
-
$1.19B(+56.8%)
$4.17B(+6.2%)
Mar 2019
-
$759.00M(-35.5%)
$3.93B(+2.3%)
Dec 2018
$3.84B(+94.9%)
$1.18B(+12.0%)
$3.84B(+13.0%)
Sep 2018
-
$1.05B(+10.9%)
$3.40B(+4.5%)
Jun 2018
-
$947.00M(+41.1%)
$3.26B(+20.7%)
Mar 2018
-
$671.00M(-8.7%)
$2.70B(+37.6%)
Dec 2017
$1.97B(-39.3%)
$735.00M(-18.8%)
$1.96B(-10.9%)
Sep 2017
-
$905.00M(+133.2%)
$2.20B(-0.6%)
Jun 2017
-
$388.00M(+687.9%)
$2.21B(-15.7%)
Mar 2017
-
-$66.00M(-106.8%)
$2.63B(-19.0%)
Dec 2016
$3.25B(+10.2%)
$975.00M(+6.2%)
$3.25B(+4.8%)
Sep 2016
-
$918.00M(+14.5%)
$3.10B(+5.6%)
Jun 2016
-
$802.00M(+45.3%)
$2.93B(+1.9%)
Mar 2016
-
$552.00M(-33.1%)
$2.88B(-2.1%)
Dec 2015
$2.95B(+1.1%)
$825.00M(+9.4%)
$2.94B(-2.9%)
Sep 2015
-
$754.00M(+0.9%)
$3.03B(-1.5%)
Jun 2015
-
$747.00M(+21.7%)
$3.07B(-2.0%)
Mar 2015
-
$614.00M(-32.7%)
$3.13B(+2.0%)
Dec 2014
$2.92B(+35.9%)
$912.00M(+14.0%)
$3.07B(+10.7%)
Sep 2014
-
$800.00M(-1.1%)
$2.78B(+5.9%)
Jun 2014
-
$809.00M(+46.3%)
$2.62B(+7.3%)
Mar 2014
-
$553.00M(-9.9%)
$2.44B(-2.4%)
Dec 2013
$2.15B(+6.9%)
$614.00M(-5.0%)
$2.50B(+5.3%)
Sep 2013
-
$646.34M(+2.5%)
$2.38B(-41.5%)
Jun 2013
-
$630.48M(+2.7%)
$4.07B(-28.1%)
Mar 2013
-
$613.79M(+25.9%)
$5.66B(-16.7%)
Dec 2012
$2.01B(-70.7%)
$487.61M(-79.1%)
$6.79B(-23.8%)
Sep 2012
-
$2.33B(+5.1%)
$8.90B(+22.5%)
Jun 2012
-
$2.22B(+27.1%)
$7.27B(+3.2%)
Mar 2012
-
$1.75B(-32.9%)
$7.04B(+3.4%)
Dec 2011
$6.84B(-3.0%)
$2.60B(+272.0%)
$6.81B(+6.2%)
Sep 2011
-
$699.88M(-64.9%)
$6.42B(-12.4%)
Jun 2011
-
$1.99B(+31.4%)
$7.32B(+4.2%)
Mar 2011
-
$1.52B(-31.3%)
$7.02B(+0.4%)
Dec 2010
$7.05B(+7.3%)
$2.21B(+37.6%)
$6.99B(+1.9%)
Sep 2010
-
$1.60B(-5.4%)
$6.87B(-2.3%)
Jun 2010
-
$1.70B(+14.0%)
$7.03B(-0.3%)
Mar 2010
-
$1.49B(-28.4%)
$7.05B(+5.0%)
Dec 2009
$6.57B(+7.9%)
$2.08B(+17.6%)
$6.71B(+4.1%)
Sep 2009
-
$1.77B(+3.1%)
$6.45B(+3.4%)
Jun 2009
-
$1.71B(+48.6%)
$6.24B(+3.4%)
Mar 2009
-
$1.15B(-36.4%)
$6.03B(-0.8%)
Dec 2008
$6.09B(+23.1%)
$1.81B(+16.5%)
$6.08B(+4.3%)
Sep 2008
-
$1.56B(+3.3%)
$5.83B(+12.2%)
Jun 2008
-
$1.51B(+25.6%)
$5.20B(+4.3%)
Mar 2008
-
$1.20B(-23.4%)
$4.98B(+6.4%)
Dec 2007
$4.95B(+14.1%)
$1.57B(+69.8%)
$4.68B(+11.5%)
Sep 2007
-
$922.45M(-28.6%)
$4.20B(+0.1%)
Jun 2007
-
$1.29B(+43.8%)
$4.19B(+6.1%)
Mar 2007
-
$898.59M(-17.1%)
$3.95B(-3.5%)
Dec 2006
$4.34B(-6.7%)
$1.08B(+17.8%)
$4.10B(-5.9%)
Sep 2006
-
$920.17M(-12.4%)
$4.35B(-3.5%)
Jun 2006
-
$1.05B(+0.8%)
$4.51B(-1.0%)
Mar 2006
-
$1.04B(-22.2%)
$4.56B(-2.0%)
Dec 2005
$4.65B(+11.3%)
$1.34B(+24.2%)
$4.65B(+3.6%)
Sep 2005
-
$1.08B(-1.5%)
$4.49B(+1.1%)
Jun 2005
-
$1.09B(-3.6%)
$4.44B(+3.1%)
Mar 2005
-
$1.14B(-3.4%)
$4.30B(+1.0%)
Dec 2004
$4.18B
$1.18B(+14.1%)
$4.26B(-0.4%)
Sep 2004
-
$1.03B(+7.3%)
$4.28B(+2.9%)
DateAnnualQuarterlyTTM
Jun 2004
-
$960.46M(-12.1%)
$4.16B(-0.6%)
Mar 2004
-
$1.09B(-8.5%)
$4.18B(+2.7%)
Dec 2003
$4.13B(+0.4%)
$1.19B(+31.0%)
$4.07B(+0.1%)
Sep 2003
-
$911.04M(-7.6%)
$4.07B(-0.1%)
Jun 2003
-
$986.14M(+0.6%)
$4.07B(+5.0%)
Mar 2003
-
$980.49M(-17.7%)
$3.88B(-1.6%)
Dec 2002
$4.11B(+19.9%)
$1.19B(+30.5%)
$3.94B(+3.3%)
Sep 2002
-
$913.40M(+15.5%)
$3.81B(+4.6%)
Jun 2002
-
$790.80M(-24.3%)
$3.65B(-1.8%)
Mar 2002
-
$1.04B(-1.9%)
$3.71B(+5.5%)
Dec 2001
$3.43B(+5.2%)
$1.07B(+43.0%)
$3.52B(+4.2%)
Sep 2001
-
$744.63M(-13.3%)
$3.38B(-23.8%)
Jun 2001
-
$859.01M(+0.9%)
$4.44B(-18.1%)
Mar 2001
-
$851.27M(-7.8%)
$5.42B(-15.7%)
Dec 2000
$3.26B(+3.0%)
$922.92M(-48.8%)
$6.42B(+1.0%)
Sep 2000
-
$1.80B(-2.0%)
$6.36B(+4.4%)
Jun 2000
-
$1.84B(-0.9%)
$6.09B(+19.9%)
Mar 2000
-
$1.86B(+116.6%)
$5.08B(+22.5%)
Dec 1999
$3.17B(+1.5%)
$857.12M(-44.2%)
$4.15B(+0.6%)
Sep 1999
-
$1.54B(+85.2%)
$4.12B(+23.0%)
Jun 1999
-
$829.55M(-10.2%)
$3.35B(+1.3%)
Mar 1999
-
$923.31M(+11.0%)
$3.31B(+3.5%)
Dec 1998
$3.12B(+9.4%)
$831.87M(+8.6%)
$3.20B(+1.6%)
Sep 1998
-
$766.08M(-2.7%)
$3.14B(+5.0%)
Jun 1998
-
$787.29M(-2.8%)
$3.00B(+2.4%)
Mar 1998
-
$810.29M(+3.8%)
$2.92B(+3.0%)
Dec 1997
$2.85B(+8.9%)
$780.92M(+26.5%)
$2.84B(+2.3%)
Sep 1997
-
$617.18M(-13.8%)
$2.77B(+1.4%)
Jun 1997
-
$716.21M(-1.2%)
$2.74B(+2.4%)
Mar 1997
-
$724.91M(+1.3%)
$2.67B(+1.9%)
Dec 1996
$2.62B(+9.8%)
$715.77M(+23.6%)
$2.62B(+2.3%)
Sep 1996
-
$579.21M(-11.1%)
$2.56B(+1.4%)
Jun 1996
-
$651.58M(-3.5%)
$2.53B(+2.3%)
Mar 1996
-
$675.00M(+2.9%)
$2.47B(+3.6%)
Dec 1995
$2.38B(+11.1%)
$655.86M(+20.8%)
$2.38B(+2.9%)
Sep 1995
-
$542.92M(-8.7%)
$2.32B(+2.6%)
Jun 1995
-
$594.65M(+0.9%)
$2.26B(+2.3%)
Mar 1995
-
$589.48M(-0.0%)
$2.21B(+2.9%)
Dec 1994
$2.14B(+15.7%)
$589.70M(+21.8%)
$2.14B(-1.1%)
Sep 1994
-
$484.03M(-10.9%)
$2.17B(+1.8%)
Jun 1994
-
$543.49M(+3.1%)
$2.13B(+6.2%)
Mar 1994
-
$527.00M(-14.2%)
$2.01B(+4.2%)
Dec 1993
$1.85B(+6.5%)
$614.07M(+37.9%)
$1.92B(+8.2%)
Sep 1993
-
$445.20M(+6.2%)
$1.78B(+0.1%)
Jun 1993
-
$419.20M(-5.9%)
$1.78B(+14.0%)
Mar 1993
-
$445.50M(-4.9%)
$1.56B(+2.1%)
Dec 1992
$1.74B(+11.8%)
$468.50M(+5.7%)
$1.53B(+0.5%)
Sep 1992
-
$443.20M(+120.3%)
$1.52B(+6.3%)
Jun 1992
-
$201.20M(-51.3%)
$1.43B(-10.7%)
Mar 1992
-
$413.20M(-10.4%)
$1.60B(+2.7%)
Dec 1991
$1.56B(+10.7%)
$461.40M(+30.9%)
$1.56B(+3.9%)
Sep 1991
-
$352.60M(-5.2%)
$1.50B(+2.0%)
Jun 1991
-
$372.00M(+0.3%)
$1.47B(+1.3%)
Mar 1991
-
$371.00M(-7.9%)
$1.45B(+3.1%)
Dec 1990
$1.41B(+15.1%)
$402.90M(+24.9%)
$1.41B(+182.7%)
Sep 1990
-
$322.60M(-8.5%)
-$1.70B(-138.7%)
Jun 1990
-
$352.70M(+7.6%)
-$712.20M(-380.8%)
Mar 1990
-
$327.90M(+112.1%)
$253.60M(-79.2%)
Dec 1989
$1.22B(+10.8%)
-$2.70B(-306.3%)
$1.22B(-12.5%)
Sep 1989
-
$1.31B(-0.6%)
$1.40B(+7.5%)
Jun 1989
-
$1.32B(+1.8%)
$1.30B(+7.3%)
Mar 1989
-
$1.30B(+151.2%)
$1.21B(+9.7%)
Dec 1988
$1.10B(+9.6%)
-$2.53B(-308.6%)
$1.10B(-25.7%)
Sep 1988
-
$1.21B(-1.4%)
$1.48B(+8.9%)
Jun 1988
-
$1.23B(+3.5%)
$1.36B(+14.3%)
Mar 1988
-
$1.19B(+155.3%)
$1.19B(+18.4%)
Dec 1987
$1.01B(+14.5%)
-$2.15B(-297.0%)
$1.01B(-21.9%)
Sep 1987
-
$1.09B(+2.9%)
$1.29B(+13.2%)
Jun 1987
-
$1.06B(+5.5%)
$1.14B(+11.9%)
Mar 1987
-
$1.00B(+153.8%)
$1.02B(+15.7%)
Dec 1986
$878.61M(+19.2%)
-$1.87B(-298.3%)
$878.60M(-18.3%)
Sep 1986
-
$940.90M(+0.3%)
$1.08B(+12.3%)
Jun 1986
-
$938.00M(+8.4%)
$957.40M(+13.1%)
Mar 1986
-
$865.50M(+151.9%)
$846.40M(+14.8%)
Dec 1985
$737.15M(+9.0%)
-$1.67B(-302.8%)
$737.10M(-11.1%)
Sep 1985
-
$822.70M(-0.5%)
$828.90M(+12.4%)
Jun 1985
-
$827.00M(+9.4%)
$737.40M(+3.6%)
Mar 1985
-
$756.20M(+148.0%)
$711.80M(+5.2%)
Dec 1984
$676.52M(+12.0%)
-$1.58B(-315.7%)
$676.70M(-70.0%)
Sep 1984
-
$731.20M(-8.8%)
$2.25B(+48.0%)
Jun 1984
-
$801.40M(+11.1%)
$1.52B(+111.1%)
Mar 1984
-
$721.10M
$721.10M
Dec 1983
$604.28M(+23.4%)
-
-
Dec 1982
$489.87M(+17.9%)
-
-
Dec 1981
$415.55M(+22.6%)
-
-
Dec 1980
$339.00M
-
-

FAQ

  • What is Abbott Laboratories annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Abbott Laboratories?
  • What is Abbott Laboratories annual EBIT year-on-year change?
  • What is Abbott Laboratories quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Abbott Laboratories?
  • What is Abbott Laboratories quarterly EBIT year-on-year change?
  • What is Abbott Laboratories TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Abbott Laboratories?
  • What is Abbott Laboratories TTM EBIT year-on-year change?

What is Abbott Laboratories annual earnings before interest & taxes?

The current annual EBIT of ABT is $6.85B

What is the all-time high annual EBIT for Abbott Laboratories?

Abbott Laboratories all-time high annual earnings before interest & taxes is $9.20B

What is Abbott Laboratories annual EBIT year-on-year change?

Over the past year, ABT annual earnings before interest & taxes has changed by +$416.00M (+6.46%)

What is Abbott Laboratories quarterly earnings before interest & taxes?

The current quarterly EBIT of ABT is $2.03B

What is the all-time high quarterly EBIT for Abbott Laboratories?

Abbott Laboratories all-time high quarterly earnings before interest & taxes is $2.88B

What is Abbott Laboratories quarterly EBIT year-on-year change?

Over the past year, ABT quarterly earnings before interest & taxes has changed by +$212.00M (+11.66%)

What is Abbott Laboratories TTM earnings before interest & taxes?

The current TTM EBIT of ABT is $7.78B

What is the all-time high TTM EBIT for Abbott Laboratories?

Abbott Laboratories all-time high TTM earnings before interest & taxes is $10.29B

What is Abbott Laboratories TTM EBIT year-on-year change?

Over the past year, ABT TTM earnings before interest & taxes has changed by +$1.03B (+15.24%)
On this page